ABOUT
TECHNOLOGY
Overview
Mechanism of Action
Pipeline
ADPKD
PATIENTS
INVESTORS
Overview
Press Releases
Events and Presentations
Financials & Filings
SEC Filings
Quarterly Results
Corporate Governance
Governance Documents
Board of Directors
Committee Composition
Analyst Coverage
Stock Information
Historical Stock Price
Investment Calculator
Insider Transactions
Fundamentals
Form 8937
Investor FAQs
Contact Us
CAREER
Toggle nav
Press Releases
.
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
Go
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
Go
Investor Alerts
Year
All Years
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Keywords
Go
Advanced Search
Search
Search Headlines Only
From
To
Asset Types
Photos
Video
Audio
Documents
Events
Standard
January 27, 2017
Regulus Announces Continuation of RG-101 Clinical Hold
FDA requests longer-term follow-up data from ongoing studies
Photos
1
December 06, 2016
Regulus Announces New Drug Development Candidates
Photos
1
November 22, 2016
Regulus to Announce New Drug Development Candidates at R&D Day on December 6, 2016
Photos
1
November 01, 2016
Regulus Reports Third Quarter 2016 Financial Results
Conference Call Today at 5:00 p.m. ET
Photos
1
October 25, 2016
Regulus to Release Third Quarter Financial Results on November 1, 2016
Conference Call and Webcast to Follow
Photos
1
Show
5
10
25
50
100
per page
«
1
…
31
32
33
34
35
36
37
…
64
»